Laurent Fischer net worth and biography

Laurent Fischer Biography and Net Worth

Laurent Fischer, M.D. is Adverum’s president and chief executive officer and serves as a director. Dr. Fischer has more than 20 years of drug development and commercialization experience in the biopharmaceutical industry. Before joining Adverum, Dr. Fischer was senior vice president and head of the Liver Therapeutic Area at Allergan, PLC. Previously, he served as chairman and chief executive officer of Tobira Therapeutics until its acquisition by Allergan in November 2016. Previously, he served as chairman and chief executive officer of Jennerex, Inc. until its acquisition by SillaJen Biotherapeutics, Inc. Prior to Jennerex, he was co-founder, president and chief executive officer of Ocera Therapeutics and president and chief executive officer of Auxeris Therapeutics, Inc. Over the span of his career, Dr. Fischer has held roles of increasing responsibility at several companies, including, RXCentric, Inc. (now part of Allscripts Healthcare Solutions, Inc.), MedVantx Inc., Dupont Pharmaceuticals, Dupont-Merck, and F. Hoffmann-La Roche.

Dr. Fischer received his undergraduate degree from the University of Geneva and his medical degree from the Geneva Medical School, Switzerland.

Dr. Fischer currently serves as chairman of the board of CTI Biopharma, as director at Mirum Pharmaceuticals, Inc. and Lycia Therapeutics, and as senior advisor on the Life Sciences Team at Frazier Healthcare Partners.

What is Laurent Fischer's net worth?

The estimated net worth of Laurent Fischer is at least $496,541.95 as of March 15th, 2023. Dr. Fischer owns 692,141 shares of Adverum Biotechnologies stock worth more than $496,542 as of March 31st. This net worth approximation does not reflect any other investments that Dr. Fischer may own. Learn More about Laurent Fischer's net worth.

How do I contact Laurent Fischer?

The corporate mailing address for Dr. Fischer and other Adverum Biotechnologies executives is 800 Saginaw Drive, Redwood City CA, 94063. Adverum Biotechnologies can also be reached via phone at (650) 656-9323 and via email at [email protected] Learn More on Laurent Fischer's contact information.

Has Laurent Fischer been buying or selling shares of Adverum Biotechnologies?

During the past quarter, Laurent Fischer has sold $32,166.42 in Adverum Biotechnologies stock. Most recently, Laurent Fischer sold 41,239 shares of the business's stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $0.78, for a transaction totalling $32,166.42. Following the completion of the sale, the chief executive officer now directly owns 692,141 shares of the company's stock, valued at $539,869.98. Learn More on Laurent Fischer's trading history.

Who are Adverum Biotechnologies' active insiders?

Adverum Biotechnologies' insider roster includes Julie Clark (Insider), Laurent Fischer (CEO), James Scopa (Director), and Kishor Soparkar (Insider). Learn More on Adverum Biotechnologies' active insiders.

Are insiders buying or selling shares of Adverum Biotechnologies?

During the last year, Adverum Biotechnologies insiders bought shares 6 times. They purchased a total of 116,925 shares worth more than $111,944.50. During the last year, insiders at the biotechnology company sold shares 5 times. They sold a total of 107,252 shares worth more than $96,809.22. The most recent insider tranaction occured on March, 15th when insider Brigit Riley sold 7,299 shares worth more than $5,693.22. Insiders at Adverum Biotechnologies own 3.3% of the company. Learn More about insider trades at Adverum Biotechnologies.

Information on this page was last updated on 3/15/2023.

Laurent Fischer Insider Trading History at Adverum Biotechnologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2023Sell41,239$0.78$32,166.42692,141View SEC Filing Icon  
9/19/2022Sell41,082$1.07$43,957.74727,380View SEC Filing Icon  
4/20/2022Buy25,000$1.11$27,750.00762,462View SEC Filing Icon  
12/8/2021Buy10,677$1.79$19,111.83View SEC Filing Icon  
3/24/2021Buy10,000$9.88$98,800.0026,292View SEC Filing Icon  
1/15/2021Buy8,600$11.53$99,158.0016,292View SEC Filing Icon  
See Full Table

Laurent Fischer Buying and Selling Activity at Adverum Biotechnologies

This chart shows Laurent Fischer's buying and selling at Adverum Biotechnologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Adverum Biotechnologies Company Overview

Adverum Biotechnologies logo
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Read More

Today's Range

Now: $0.72
Low: $0.72
High: $0.76

50 Day Range

MA: $0.72
Low: $0.62
High: $0.85

2 Week Range

Now: $0.72
Low: $0.53
High: $1.82


109,783 shs

Average Volume

422,737 shs

Market Capitalization

$71.55 million

P/E Ratio


Dividend Yield